UK News
16/3/23 - Malfunctioning immune cell linked to long COVID
The malfunctioning behaviour of an immune cell could be linked to specific symptoms of long COVID,
opening the way to treatments, British researchers have reported. More
15/3/23 - Common cough medicines withdrawn
The opioid pholcodine, a common component of cough and cold medicines, is to be removed from the
British market, it was announced yesterday. More
15/3/23 - Caffeine metabolism speed may impact diabetes
The impact of a high blood caffeine level has been explored by researchers looking at body
mass and diabetes. More
14/3/23 - New drive to improve safe baby sleeping
Health visitors should be responsible for discussing safe sleeping practices with vulnerable families
with young babies, according to a new report. More
13/3/23 - Urine test predicts bladder cancer years before diagnosis
Bladder cancer can be detected up to 12 years before symptoms appear, thanks to a test that looks
for genetic mutations in urine, a conference has heard. More
10/3/23 - Revolutionary map of neurons published
The first map to show every neuron, wired together in the brain of the fruit fly larva was published last night. More
9/3/23 - New bone cancer drug unveiled
A new drug could treat the main types of primary bone cancer without toxic side effects, British researchers say. More
8/3/23 - New drug for obese could cut stones
NHS specialist weight loss services are to have access to a drug which can reduce body weight
by about 12%, it was announced today. More
6/3/23 - Gene test could predict bowel cancer therapy success
A gene test already used by the NHS could help to predict if late-stage bowel cancer patients will
benefit from chemotherapy. More
6/3/23 - Fertility affected by genetic variants
Fertility is affected by mechanisms that influence reproductive biology and human behaviour,
a new study has shown. More
3/3/23 - Peptide to treat MND
A peptide given as a nasal spray might treat motor neurone disease, British scientists have suggested.
More
2/3/23 - 20-year epigenetics mystery solved
A 20-year mystery of how epigenetic modifications act as traffic lights to control gene expression
has finally been uncovered, British scientists have announced. More
2/3/23 - Move opioid patients to alternative therapies - guidance
A drive to reduce opioid prescriptions in primary care is having success as patients move to therapeutic
alternatives to drugs, it was announced today. More
1/3/23 - Health boost from brief physical activity
One in ten premature deaths could be avoided if everyone achieved just half the recommended level
of physical activity, researchers say today. More
1/3/23 - Injury risk higher for e-scooters than bicycles
Users of e-scooters face a significantly greater risk of serious injury than cyclists, according
to an analysis published today. More
28/2/23 - Dystrophin link to cancer
The dystrophin gene may have a role in cancer, British researchers have reported.
More
27/2/23 - Head injury a 'risk factor for developing brain cancer'
A mechanism that explains how head injury could be a risk factor for a rare brain tumour has been
revealed by British researchers. More
24/2/23 - Promising early gene therapy trial for 'childhood dementia'
An investigational gene therapy for a syndrome that leads to a form of childhood dementia has shown
promising early results in a proof-of-concept study, a conference will hear today. More
23/2/23 - Urban hayfever symptoms 'worse than rural areas'
People living in urban areas have worse hay fever symptoms than those living in rural areas of
the country, according to the first study of its kind. More
22/2/23 - Concern over new form of mpox
A new severe form of mpox has a high mortality rate in people with advanced HIV, researchers report
today. More
22/2/23 - Monthly physical activity benefits brain
A new link has been reported between regular exercise and improved cognitive function later in
life. More
21/2/23 - Three COVID treatments gain approval
Regulators today endorse three medicines for treating adults with COVID-19 as part of a clinical
and cost-effectiveness review. More
Printer friendly page